Anas M. Abdel Rahman - Genetic Mutations

Author Information

Anas M. A. Rahman is a researcher affiliated with the Department of Genetics at King Faisal Specialist Hospital and Research Center (KFSHRC) in Riyadh, Saudi Arabia. His research spans various topics in genetics and related fields, contributing significantly to our understanding of genetic influences on diseases and the molecular mechanisms underlying various medical conditions.

Research Contributions

Anas M. A. Rahman has made substantial contributions to the field of genetics and molecular biology. His work includes investigating the proteomic and metabolomic profiles of various diseases, such as endometrial cancer, systemic lupus erythematosus, and obstructive sleep apnea. He has also explored the genetic variants associated with disease activity and the molecular mechanisms driving cellular differentiation and tumor growth. Rahman's research is characterized by its interdisciplinary approach, combining proteomics, metabolomics, and genetic analysis to uncover novel insights into disease mechanisms and potential therapeutic targets.

Aliases

Anas M. A. Rahman is also known by several aliases, including Anas M. A. Rahman, Anas M Abdel Rahman, Anas Abd El Rahman, Anas A Rahman, Anas M. Abdel Rahman, Anas Abdel Rahman, and Anas A. Rahman.

Publication and Citation Metrics

Publication Year	Title	DOI
2022	Proteomic Analysis of Endometrial Cancer Tissues from Patients with Type 2 Diabetes Mellitus	10.3390/life12040491
2021	Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy Against Breast Cancer Cell Models.	10.2174/1871520621666210910101349
2021	Insecticidal, antimicrobial and antioxidant activities of essential oil from Lavandula latifolia L. and its deterrent effects on Euphoria leucographa	10.1016/J.INDCROP.2021.113740
2020	Association of genetic variants of interleukin-1β gene -511T/C (rs16944) and +3954C/T (rs1143634) and serum levels of pentaxin (PTX3) and interleukin -1β (IL-1β) with disease activity of systemic lupus erythematosus patients	10.1016/j.genrep.2020.100960
2020	N-Acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation.	10.1074/jbc.RA120.015595
2020	N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation	10.1074/jbc.RA120.015595
2020	Targeted Metabolomics Analysis on Obstructive Sleep Apnea Patients after Multilevel Sleep Surgery	10.3390/metabo10090358
2019	Proteomic Analysis of Morphologically Changed Tissues after Prolonged Dexamethasone Treatment	10.3390/ijms20133122
2019	Caveolin-1 Y14 phosphorylation suppresses tumor growth while promoting invasion	10.18632/oncotarget.27313
2019	Metabolomics Distinguishes DOCK8 Deficiency from Atopic Dermatitis: Towards a Biomarker Discovery	10.3390/metabo9110274